BOOST Pharma ApS: Financial statements 2022
CVR: 41120495
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BOOST Pharma ApS (CVR 41120495) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -3,499,684 and a net result of DKK -4,197,998 compared with DKK -2,224,194 the year before. Equity in the 2022 report amounted to DKK -6,445,537. The company had 1 employee in the financial year.
- Gross Profit
- DKK -3,499,684
- Profit/Loss
- DKK -4,197,998
- Equity
- DKK -6,445,537
- Total Assets
- DKK 4,314,094
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -3.5 mio. | -4.2 mio. | -6.4 mio. | 1 |
| 2021 | - | -1.3 mio. | -2.2 mio. | -2.2 mio. | 1 |
| 2020 | - | -21 t. | -63 t. | -23 t. | - |
Keep an eye on BOOST Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BOOST Pharma ApS has published its annual report for 2021. Gross profit came to DKK -1,319,978, and the net result was DKK -2,224,194.
As of February 9, 2022, Ingelise Saunders is registered as director of BOOST Pharma ApS.
As of February 9, 2022, Lilian Karin Florence Walter Jallow has stepped down as director of BOOST Pharma ApS.
About BOOST Pharma ApS
BOOST Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Thalsgård Schambye. The company is owned by BOOST Pharma AB. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity in the 2025 report amounted to DKK -11,850,535.